Lexavon

Levofloxacin, the active ingredient in Lexavon, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial infections of the eye such as conjunctivitis, keratitis and blepharitis in patients requiring prescription therapy.

GNH USA supplies Lexavon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lexavon, a fluoroquinolone ophthalmic antibiotic, is indicated for bacterial infections of the ocular surface.

- Bacterial conjunctivitis: reduces bacterial load and promotes resolution of conjunctival infection. - Bacterial keratitis: eradicates pathogenic bacteria to prevent corneal damage. - Blepharitis: controls bacterial overgrowth on the eyelid margin, improving inflammation and symptoms.

Adverse reactions may occur with ocular administration of Lexavon.

Common Side Effects: - Eye irritation: transient burning or stinging sensation. - Redness: mild conjunctival hyperemia. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance. - Tearing: increased lacrimation. - Photophobia: sensitivity to light.

Serious or Rare Side Effects: - Corneal ulceration: progressive corneal damage requiring immediate attention. - Allergic reaction: swelling, rash, or severe itching of the eye. - Stevens‑Johnson syndrome: rare systemic hypersensitivity with mucosal involvement. - Severe ocular inflammation: marked swelling or pain indicating possible infection progression.

Lexavon should be used with caution and according to professional guidance.

- Hypersensitivity: avoid in patients with known allergy to fluoroquinolones. - Contact lenses: do not wear lenses during treatment unless advised. - Infection monitoring: discontinue if condition worsens or new symptoms appear. - Prescription use: follow the prescriber's instructions precisely. - Storage: Store at room temperature: keep in original container, protect from light and moisture.

Lexavon may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: increased risk of tendon toxicity. - Corticosteroid eye drops: may mask signs of infection. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: possible pupil size alteration. - NSAID eye drops: additive ocular irritation. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring.